本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cogent Biosciences, Inc.

33.38
-0.0350-0.10%
成交量:111.63萬
成交額:3,719.45萬
市值:57.91億
市盈率:-15.45
高:33.58
開:33.42
低:32.85
收:33.41
52周最高:43.73
52周最低:11.60
股本:1.74億
流通股本:1.67億
量比:0.65
換手率:0.67%
股息:- -
股息率:- -
每股收益(TTM):-2.1600
每股收益(LYR):-2.5504
淨資產收益率:-109.74%
總資產收益率:-43.84%
市淨率:12.38
市盈率(LYR):-13.09

資料載入中...

2024/03/22

重要事件披露

Form 8-K - Current report
2024/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/16

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

重要事件披露

Form 8-K - Current report
2024/02/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/11

重要事件披露

Form 8-K - Current report
2023/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/08

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans